DIRECT EVIDENCE OF A FUNCTIONAL SEPARATION OF ALLOREACTIVE T-LYMPHOCYTES FROM BYSTANDER CELLS INFILTRATING RAT ALLOGRAFTS - INTERLEUKIN-2 RECEPTOR-POSITIVE CELLS REACTING WITH THE MONOCLONAL-ANTIBODY ART-18 MEDIATING 2ND-SET REJECTION

被引:3
作者
HEIDECKE, CD [1 ]
BRAUER, R [1 ]
SCHNEIDEREICKE, J [1 ]
SCHILLING, T [1 ]
WOLFF, S [1 ]
DIAMANTSTEIN, T [1 ]
机构
[1] FREE UNIV BERLIN,INST IMMUNOL,W-1000 BERLIN 33,GERMANY
关键词
D O I
10.1097/00007890-199007000-00019
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In this study we examined the functional capacity of unseparated, IL-2R positive and IL-2R negative leukocytes infiltrating BN rat hearts or kidneys grafted into allogeneic LEW rats. Upon adoptive transfer into syngeneic LEW recipients, splenocytes or day-3 graft infiltrate cells of either cardiac or renal transplants were ineffective to alter BN cardiac test graft survival (controls 7.8 ± 0.8 day). However, adoptive transfer of day-5 heart infiltrate cells resulted in a delay of test graft rejection (9.4±0.7 day, P<0.001), while day-5 kidney-graft-infiltrating cells produced second set rejection (6.2±0.5, P<0.001). Specificity controls of day-5 cells infiltrating DA heart or kidney grafts rejected at 7.8± 0.8 or 7.7±0.5 days. Following separation into IL-2R positive and negative subpopulations by use of the mAB ART 18, IL-2R positive but not IL-2R negative cells caused second set rejection in both the renal and the cardiac model (6.2±0.4, respectively, 6.3+0.5 days, P <0.001 or P<0.005). Furthermore, in the kidney model IL-2R positive nylon-wool nonadherent cells also caused second set rejection (6.2±0.4, P<0.005) suggesting that IL-2R positive T cells present in the graft at maximal infiltration are the mediators of rejection. Thus, it appears that these cells can be phenotypically and functionally separated from bystander cells. © 1990 by Williams & Wilkins.
引用
收藏
页码:101 / 106
页数:6
相关论文
共 34 条
[1]   PHENOTYPE, ACTIVATION STATUS, AND SUPPRESSOR ACTIVITY OF HOST LYMPHOCYTES DURING ACUTE REJECTION AND AFTER CYCLOSPORINE-INDUCED UNRESPONSIVENESS OF RAT CARDIAC ALLOGRAFTS [J].
ARAUJO, JL ;
KUPIECWEGLINSKI, JW ;
ARANEDA, D ;
TOWPIK, E ;
HEIDECKE, CD ;
WILLIAMS, JM ;
TILNEY, NL .
TRANSPLANTATION, 1985, 40 (03) :278-284
[2]   CELLULAR BASIS OF ALLOGRAFT-REJECTION [J].
ASCHER, NL ;
HOFFMAN, RA ;
HANTO, DW ;
SIMMONS, RL .
IMMUNOLOGICAL REVIEWS, 1984, 77 :217-232
[3]   INTERLEUKIN-2 RECEPTOR TARGETED CYTO-TOXICITY INTERLEUKIN-2 RECEPTOR MEDIATED ACTION OF A DIPHTHERIA-TOXIN RELATED INTERLEUKIN-2 FUSION PROTEIN [J].
BACHA, P ;
WILLIAMS, DP ;
WATERS, C ;
WILLIAMS, JM ;
MURPHY, JR ;
STROM, TB .
JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 167 (02) :612-622
[4]   CELLULAR-REQUIREMENTS FOR RENAL-ALLOGRAFT REJECTION IN THE ATHYMIC NUDE RAT [J].
BOLTON, EM ;
GRACIE, JA ;
BRIGGS, JD ;
KAMPINGA, J ;
BRADLEY, JA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 169 (06) :1931-1946
[5]   FUNCTION AND MIGRATION OF SUPPRESSOR LYMPHOCYTES FROM CYCLOSPORINE-TREATED HEART GRAFT RECIPIENTS [J].
BORDESAZNAR, J ;
KUPIECWEGLINSKI, JW ;
DUARTE, AJS ;
MILFORD, EL ;
STROM, TB ;
TILNEY, NL .
TRANSPLANTATION, 1983, 35 (02) :185-190
[6]   TRANSIENT EXPRESSION OF INTERLEUKIN-2 RECEPTORS - CONSEQUENCES FOR T-CELL GROWTH [J].
CANTRELL, DA ;
SMITH, KA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1983, 158 (06) :1895-1911
[7]   THE ROLE OF HELPER T-CELL PRODUCTS IN MOUSE B-CELL DIFFERENTIATION AND ISOTYPE REGULATION [J].
COFFMAN, RL ;
SEYMOUR, BWP ;
LEBMAN, DA ;
HIRAKI, DD ;
CHRISTIANSEN, JA ;
SHRADER, B ;
CHERWINSKI, HM ;
SAVELKOUL, HFJ ;
FINKELMAN, FD ;
BOND, MW ;
MOSMANN, TR .
IMMUNOLOGICAL REVIEWS, 1988, 102 :5-28
[8]   SPECIFIC CYTOTOXIC T-CELLS ARE FOUND IN THE NONREJECTED KIDNEYS OF BLOOD-TRANSFUSED RATS [J].
DALLMAN, MJ ;
WOOD, KJ ;
MORRIS, PJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 165 (02) :566-571
[9]   THE ROLES OF HOST AND DONOR CELLS IN THE REJECTION OF SKIN ALLOGRAFTS BY T-CELL-DEPRIVED RATS INJECTED WITH SYNGENEIC T-CELLS [J].
DALLMAN, MJ ;
MASON, DW ;
WEBB, M .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1982, 12 (06) :511-518
[10]   THE INTERLEUKIN-2 RECEPTOR, ITS PHYSIOLOGY AND A NEW APPROACH TO A SELECTIVE IMMUNOSUPPRESSIVE THERAPY BY ANTI-INTERLEUKIN-2 RECEPTOR MONOCLONAL-ANTIBODIES [J].
DIAMANTSTEIN, T ;
OSAWA, H .
IMMUNOLOGICAL REVIEWS, 1986, 92 :5-27